David F. Hale
CIK: 0001024004
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Dermata Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jan 2, 2026DRMA
Dermata Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
2.5K shares- - Jan 23, 2025DRMA
Dermata Therapeutics, Inc.
Award(A)Indirect78.7K shares- - Jan 21, 2025DRMA
Dermata Therapeutics, Inc.
Award(A)IndirectWarrant (Right to Buy)
78.7K shares- - Jan 13, 2025DRMA
Dermata Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 2, 2026 | DRMA Dermata Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 2,500 | - | - | Direct |
| Jan 23, 2025 | DRMA Dermata Therapeutics, Inc. | Award(A) | 78,741 | - | $0 | Indirect |
| Jan 21, 2025 | DRMA Dermata Therapeutics, Inc. | Award(A) Warrant (Right to Buy) | 78,741 | - | - | Indirect |
| Jan 13, 2025 | DRMA Dermata Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 5,000 | - | - | Direct |
1-4 of 4 transactions
About HALE DAVID F
HALE DAVID F (SEC CIK 0001024004) files insider reports with the SEC as Director of Dermata Therapeutics, Inc. (DRMA).
Signal8 holds 3 ownership filings by HALE DAVID F, all Form 4s, filed between Jan 14, 2025 and Jan 6, 2026. Those filings report 4 transactions, from Jan 13, 2025 to Jan 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on HALE DAVID F's filings is in SAN DIEGO, CA.
Recent filings by HALE DAVID F
Other insiders filing for Dermata Therapeutics, Inc. (DRMA)
- PROEHL GERALD T, PRESIDENT, CHAIRMAN, CEO
- Van Hoose Kyri K., SVP, CFO
- Scott Kathleen D., Director
- Bedoya-Toro Munera Maria E, SVP, Regulatory Affairs
- WIERENGA WENDELL, Director
- Nardo Christopher J., Senior VP, CDO